The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Assessment of HER2 status from an epidemiology study in tumor tissue samples of gastric and gastro-esophageal junction cancer: Results from the french cohort of the HER-EAGLE study.
Genevieve Monges
Honoraria - Roche
Benoit Terris
No relevant relationships to disclose
Marie-Pierre Chenard
Honoraria - Roche
Frederique Penault-Llorca
Consultant or Advisory Role - Roche
Honoraria - Roche
Sophie Beauclair
Employment or Leadership Position - Roche
Frederic Bibeau
Honoraria - Roche
Jean-François Emile
No relevant relationships to disclose
Alain Volant
No relevant relationships to disclose
Laurent Doucet
No relevant relationships to disclose